Trials / Completed
CompletedNCT02151734
Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 242 (actual)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- All
- Age
- 12 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, double-dummy, double-blind, randomized, active-controlled, parallel group phase 3 clinical trial to evaluate the efficacy and safety of KALOMIN™ Tab. in patients with acute bronchitis. The aim of this clinical trial is to demonstrate that KALOMIN™ Tab. is clinically non-inferior to Umckamin syrup, as assessed by BSS(Bronchitis Severity Score), in the treatment of acute bronchitis after 7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KALOMIN™ Tab. | |
| DRUG | Umckamin syrup |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2013-12-01
- First posted
- 2014-05-30
- Last updated
- 2014-05-30
Source: ClinicalTrials.gov record NCT02151734. Inclusion in this directory is not an endorsement.